Investigational Site Number : 380002

Torino 10126

0 studies enrolling now · 1 studies all time

What they study most

Hematological Malignancy

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed